IMS 0.00% 69.0¢ impelus limited

Game changer, page-17

  1. 7,393 Posts.
    lightbulb Created with Sketch. 456
    The comment below would imply to me they were not live in the market until test and learn was fully completed. To bill customers while you are still testing could be disastrous as you can damage brand name, turn customers away and make costly mistakes. Could be good to contact company for clarification on this point though.

    'Two products are now live in market, acquiring customers and generating revenue. A
    third product will be launched imminently.'
 
watchlist Created with Sketch. Add IMS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.